
News • Immunology
How obesity impairs vaccine response
Being overweight can reduce vaccine effectiveness, new research finds. The findings explore differences in immune response, and may lead to more effective vaccines for patients with obesity.

Being overweight can reduce vaccine effectiveness, new research finds. The findings explore differences in immune response, and may lead to more effective vaccines for patients with obesity.

Drawbacks of GLP-1 discontinuation: People tend to regain weight rapidly after stopping weight-loss drugs - and faster than after ending behavioural weight loss programmes - according to new research.

Not all PCOS is the same: Researchers identified four subgroups with distinct symptoms and different responses to treatment – opening the door to precision medicine for millions of women worldwide.

GLP-1 receptor agonists are widely prescribed for individuals with diabetes and weight loss. However, these medications may adversely affect the interpretation of cancer imaging, new research finds.

International research led by Leipzig and Ulm universities creates first standardized leptin reference values for all ages and weight classes, advancing personalized medicine

Saving money, at a cost: To undergo bariatric and weight reduction surgery, more and more patients turn to institutions outside their home country – potentially putting their health at risk.

Soccer is not only a fun and popular sport, but can also help prevent many lifestyle-related conditions, including diabetes, heart disease, obesity, several cancers, and mental health challenges.

Severe obesity comes with serious health risks, which can be reduced with metabolic and bariatric surgery. Now, a landmark study reveals which operation is most effective or cost-effective.

Losing weight is a great way to improve one's overall health. But, are these benefits gone once a person is gaining weight again? Not necessarily, a new study points out.

Using 3D imaging and deep learning AI, researchers have developed a new way to accurately assess body fat and muscle distribution, which are crucial for understanding health risks.

Metabolic-associated fatty liver disease has 2 types – a liver-specific type and a systemic type that affects other organs and tissues. This discovery could lead to better diagnosis and treatments.

Why does obesity increase the risk of cancer and possibly metastasis? Researchers in Spain are currently investigating this very question.

When people quit smoking, they often put on the pounds instead – but why is that? New research on dietary habits of smokers and non-smokers may provide us with an answer.

A 12-week digital weight management programme has been shown to achieve clinically meaningful weight loss in patients with high BMI plus hypertension, diabetes or both.

Popular medications like Ozempic and Wegovy that are used to treat diabetes and obesity are associated with an increased risk of aspiration pneumonia following endoscopy, a new study finds.

Adults who had amblyopia (lazy eye) in childhood are more likely to experience hypertension, obesity, and metabolic syndrome as an adult, as well as a higher heart attack risk, finds a new study.

This February, the Norwegian Institute of Public Health officially launched the ‘Joint Action on cancer and other non-communicable disease prevention project‘ (JA PreventNCD). In the four-year-initiative, 22 EU member states plus Iceland, Norway and Ukraine have joined forces to combat the increasing burden of non-communicable diseases (NCDs) across national borders.

Millions suffer from obesity, an epidemic that continues to trend upward. While bariatric surgery is a very effective treatment option, a new survey reveals common misconceptions about the procedure.

When your stomach is full after a large meal, certain receptors are activated to tell the brain. A newly developed capsule could provoke this fullness signal early, potentially helping with treating obesity.